| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/HC0102.101437 |
| P698 | PubMed publication ID | 11772885 |
| P50 | author | Alexandra Abramsson | Q96640076 |
| Christer Betsholtz | Q5574883 | ||
| P2093 | author name string | Moshe Shani | |
| Denise Paulin | |||
| Hayk Papayan | |||
| Orjan Berlin | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 112-117 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Analysis of mural cell recruitment to tumor vessels | |
| P478 | volume | 105 |
| Q35757079 | AECHL-1, a novel triterpenoid, targets tumor neo-vasculature and impairs the endothelial cell cytoskeleton. |
| Q35843474 | Abnormalities of Basement Membrane on Blood Vessels and Endothelial Sprouts in Tumors |
| Q24806905 | Additive effects of PDGF receptor beta signaling pathways in vascular smooth muscle cell development |
| Q50494479 | Adipose stromal cell tubule network model provides a versatile tool for vascular research and tissue engineering. |
| Q29614541 | Angiogenesis in health and disease |
| Q30440490 | Cellular signaling molecules as therapeutic targets in glioblastoma multiforme |
| Q37382109 | Cellular source and amount of vascular endothelial growth factor and platelet-derived growth factor in tumors determine response to angiogenesis inhibitors |
| Q55614021 | Chemo-manipulation of tumor blood vessels by a metal-based anticancer complex enhances antitumor therapy. |
| Q28397396 | Chronic arsenic exposure and angiogenesis in human bronchial epithelial cells via the ROS/miR-199a-5p/HIF-1α/COX-2 pathway |
| Q41869709 | Coronary microvascular pericytes are the cellular target of sunitinib malate-induced cardiotoxicity |
| Q35103262 | Desmin ensheathment ratio as an indicator of vessel stability: evidence in normal development and in retinopathy of prematurity |
| Q34091609 | Desmin expression in colorectal cancer stroma correlates with advanced stage disease and marks angiogenic microvessels. |
| Q39411007 | Diabetes and Wound Angiogenesis |
| Q39750399 | Double target for tumor mass destruction. |
| Q49384248 | Dual roles of endothelial FGF-2-FGFR1-PDGF-BB and perivascular FGF-2-FGFR2-PDGFRβ signaling pathways in tumor vascular remodeling |
| Q34367285 | Early contribution of pericytes to angiogenic sprouting and tube formation |
| Q38849027 | Endothelial Jagged1 promotes solid tumor growth through both pro-angiogenic and angiocrine functions. |
| Q39961300 | Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors |
| Q28508460 | Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities |
| Q34090428 | Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy |
| Q27317909 | Expression of the growth factor progranulin in endothelial cells influences growth and development of blood vessels: a novel mouse model |
| Q37260990 | Fibroblast growth factor-1 (FGF-1) loaded microbeads enhance local capillary neovascularization |
| Q33728242 | Flattened microvessel independently predicts poor prognosis of patients with non-small cell lung cancer |
| Q34162432 | Focal Adhesion Assembly in Myofibroblasts Fosters a Microenvironment that Promotes Tumor Growth |
| Q38190887 | From pericytes to perivascular tumours: correlation between pathology, stem cell biology, and tissue engineering |
| Q29619719 | High interstitial fluid pressure - an obstacle in cancer therapy |
| Q37420191 | Identification of blood vascular endothelial stem cells by the expression of protein C receptor |
| Q31144032 | Imaging of angiogenesis: from microscope to clinic |
| Q48892078 | In-vivo quantification of the revascularization of a human acellular dermis seeded with EPCs and MSCs in co-culture with fibroblasts and pericytes in the dorsal chamber model in pre-irradiated tissue |
| Q35088365 | Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization |
| Q35102889 | Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts |
| Q40640822 | Interaction of plasminogen-related protein B with endothelial and smooth muscle cells in vitro |
| Q35131527 | Intrinsic susceptibility MRI identifies tumors with ALKF1174L mutation in genetically-engineered murine models of high-risk neuroblastoma |
| Q80490298 | Lactate adversely affects the in vitro formation of endothelial cell tubular structures through the action of TGF-beta1 |
| Q47997045 | Loss of Pericytes in Radiation Necrosis after Glioblastoma Treatments. |
| Q35743851 | Manipulating angiogenesis in medicine |
| Q42579675 | Microvessel Density Is Associated with VEGF and α-SMA Expression in Different Regions of Human Gastrointestinal Carcinomas |
| Q28081657 | Molecular Connections between Cancer Cell Metabolism and the Tumor Microenvironment |
| Q53512519 | Molecular mechanisms underlying therapeutic potential of pericytes. |
| Q41888952 | NO mediates mural cell recruitment and vessel morphogenesis in murine melanomas and tissue-engineered blood vessels |
| Q92592099 | Nanoparticle Interactions with the Tumor Microenvironment |
| Q48378493 | Neuron-specific ablation of PDGF-B is compatible with normal central nervous system development and astroglial response to injury |
| Q37111555 | Not all MSCs can act as pericytes: functional in vitro assays to distinguish pericytes from other mesenchymal stem cells in angiogenesis. |
| Q42804271 | PDGF-D is a potent transforming and angiogenic growth factor |
| Q37407269 | PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival |
| Q48175878 | PDGFRβ-P2A-CreERT2 mice: a genetic tool to target pericytes in angiogenesis. |
| Q34312222 | Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan |
| Q37686482 | Pericyte-endothelial crosstalk: implications and opportunities for advanced cellular therapies |
| Q92421246 | Pericytes in Breast Cancer |
| Q92421241 | Pericytes in Glioblastomas: Multifaceted Role Within Tumor Microenvironments and Potential for Therapeutic Interventions |
| Q92421251 | Pericytes in Sarcomas and Other Mesenchymal Tumors |
| Q38528174 | Pericytes in sarcomas of bone |
| Q41916240 | Pericytes limit tumor cell metastasis |
| Q36695062 | Pericytes on the tumor vasculature: jekyll or hyde? |
| Q33597254 | Platelet-derived growth factor-B normalizes micromorphology and vessel function in vascular endothelial growth factor-A-induced squamous cell carcinomas |
| Q37257191 | Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer |
| Q35103296 | Regulated angiogenesis and vascular regression in mice overexpressing vascular endothelial growth factor in airways. |
| Q36680668 | Review of the pericyte during angiogenesis and its role in cancer and diabetic retinopathy |
| Q36284948 | Role of bone marrow-derived cells in angiogenesis: focus on macrophages and pericytes |
| Q40544944 | Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturation |
| Q29615222 | Role of platelet-derived growth factors in physiology and medicine |
| Q36746579 | Sinusoidal remodeling and angiogenesis: a new function for the liver-specific pericyte? |
| Q36775480 | Soluble receptor-mediated selective inhibition of VEGFR and PDGFRbeta signaling during physiologic and tumor angiogenesis |
| Q37806811 | Stem cells in tumor angiogenesis |
| Q38161389 | The dynamics of developmental and tumor angiogenesis-a comparison. |
| Q33680520 | The effect of FGF-1 loaded alginate microbeads on neovascularization and adipogenesis in a vascular pedicle model of adipose tissue engineering |
| Q28191178 | The enigmatic role of angiopoietin-1 in tumor angiogenesis |
| Q39036151 | The role of endoglin in post-ischemic revascularization. |
| Q24683881 | The role of pericytes in blood-vessel formation and maintenance |
| Q37373638 | Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions relevance of compromised structural integrity for intraplaque microvascular leakage. |
| Q37684615 | Thrombospondin-2 overexpression in the skin of transgenic mice reduces the susceptibility to chemically induced multistep skin carcinogenesis |
| Q39325325 | Transforming growth factor-beta1 induces microvascular abnormalities through a down-modulation of neural cell adhesion molecule in human hepatocellular carcinoma |
| Q35639948 | Tumor-induced loss of mural Connexin 43 gap junction activity promotes endothelial proliferation |
| Q26782015 | Type-2 pericytes participate in normal and tumoral angiogenesis |
| Q37598929 | VEGF as an inhibitor of tumor vessel maturation: implications for cancer therapy |
| Q35855622 | Vascular endothelial growth factor and other signaling pathways in developmental and pathologic angiogenesis |
Search more.